148 related articles for article (PubMed ID: 27446474)
1. Far-western blotting as a solution to the non-specificity of the anti-erythropoietin receptor antibody.
Fecková B; Kimáková P; Ilkovičová L; Szentpéteriová E; Debeljak N; Solárová Z; Sačková V; Šemeláková M; Bhide M; Solár P
Oncol Lett; 2016 Aug; 12(2):1575-1580. PubMed ID: 27446474
[TBL] [Abstract][Full Text] [Related]
2. Methylation of the first exon in the erythropoietin receptor gene does not correlate with its mRNA and protein level in cancer cells.
Fecková B; Kimáková P; Ilkovičová L; Szentpéteriová E; Macejová M; Košuth J; Zulli A; Debeljak N; Hudler P; Jašek K; Kašubová I; Kubatka P; Solár P
BMC Genet; 2019 Jan; 20(1):1. PubMed ID: 30606107
[TBL] [Abstract][Full Text] [Related]
3. Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells.
Jeong JY; Feldman L; Solar P; Szenajch J; Sytkowski AJ
Int J Cancer; 2008 Jan; 122(2):274-80. PubMed ID: 17893874
[TBL] [Abstract][Full Text] [Related]
4. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
[TBL] [Abstract][Full Text] [Related]
5. Expression of erythropoietin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorigenesis.
Gombos Z; Danihel L; Repiska V; Acs G; Furth E
Indian J Pathol Microbiol; 2011; 54(2):273-8. PubMed ID: 21623073
[TBL] [Abstract][Full Text] [Related]
6. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface.
Migliaccio AR; Migliaccio G; D'Andrea A; Baiocchi M; Crotta S; Nicolis S; Ottolenghi S; Adamson JW
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11086-90. PubMed ID: 1722318
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the erythropoietin receptor gene in patients with myeloproliferative and myelodysplastic syndromes.
Mittelman M; Gardyn J; Carmel M; Malovani H; Barak Y; Nir U
Leuk Res; 1996 Jun; 20(6):459-66. PubMed ID: 8709617
[TBL] [Abstract][Full Text] [Related]
8. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G
World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D
Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111
[TBL] [Abstract][Full Text] [Related]
10. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors.
Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V
Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826
[TBL] [Abstract][Full Text] [Related]
11. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
[TBL] [Abstract][Full Text] [Related]
12. The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation.
Sawyer ST; Hankins WD
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6849-53. PubMed ID: 8341708
[TBL] [Abstract][Full Text] [Related]
13. Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
Rainville N; Jachimowicz E; Wojchowski DM
Expert Opin Ther Targets; 2016; 20(3):287-301. PubMed ID: 26419263
[TBL] [Abstract][Full Text] [Related]
14. Production and processing of erythropoietin receptor transcripts in brain.
Chin K; Yu X; Beleslin-Cokic B; Liu C; Shen K; Mohrenweiser HW; Noguchi CT
Brain Res Mol Brain Res; 2000 Sep; 81(1-2):29-42. PubMed ID: 11000476
[TBL] [Abstract][Full Text] [Related]
15. Dominant negative effect of a truncated erythropoietin receptor (EPOR-T) on erythropoietin-induced erythroid differentiation: possible involvement of EPOR-T in ineffective erythropoiesis of myelodysplastic syndrome.
Shimizu R; Komatsu N; Miura Y
Exp Hematol; 1999 Feb; 27(2):229-33. PubMed ID: 10029161
[TBL] [Abstract][Full Text] [Related]
16. Location and the functionality of erythropoietin receptor(s) in A2780 cells.
Solár P; Hrčková G; Varinská L; Solárová Z; Kriška J; Uhrínová I; Kello M; Mojžiš J; Fedoročko P; Sytkowski AJ
Oncol Rep; 2012 Jul; 28(1):141-6. PubMed ID: 22552716
[TBL] [Abstract][Full Text] [Related]
17. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment.
Xie Z; Wu X; Qiu Q; Gong Y; Song Y; Gu Q; Li C
Curr Eye Res; 2007 Sep; 32(9):757-64. PubMed ID: 17882708
[TBL] [Abstract][Full Text] [Related]
18. Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells.
Elliott S; Busse L; McCaffery I; Rossi J; Sinclair A; Spahr C; Swift S; Begley CG
J Immunol Methods; 2010 Jan; 352(1-2):126-39. PubMed ID: 19887071
[TBL] [Abstract][Full Text] [Related]
19. Human erythropoietin increases the pro-angiogenic potential of A2780 ovarian adenocarcinoma cells under hypoxic conditions.
Kriška J; Solár P; Varinská L; Solárová Z; Kimáková P; Mojžiš J; Fedoročko P; Sytkowski AJ
Oncol Rep; 2013 Sep; 30(3):1455-62. PubMed ID: 23807540
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.
Våtsveen TK; Sponaas AM; Tian E; Zhang Q; Misund K; Sundan A; Børset M; Waage A; Brede G
J Hematol Oncol; 2016 Aug; 9(1):75. PubMed ID: 27581518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]